REQUEST A DEMO
Total
USD $0.00
Search more companies

Raizen Biotecnologia S.A. (Brazil)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Secondary Activities: All Other Professional, Scientific, and Technical Services
Full name: Raizen Biotecnologia S.A. Profile Updated: October 18, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Portuguese Download a sample report

Raizen Biotecnologia S.A. is an enterprise in Brazil, with the main office in Guariba. The company operates in the Research and Development in the Physical, Engineering, and Life Sciences industry. It was incorporated on April 24, 2008.

Headquarters
Rodovia Brigadeiro Faria Lima Km. 322 S/N, Sala 03 Predio Adm Usina Ac. E Alc. Bonfim, Zona Rural
Guariba; Sao Paulo; Postal Code: 14840000

Contact Details: Purchase the Raizen Biotecnologia S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Raizen Biotecnologia S.A. report to view the information.
Outstanding Shares:
Purchase the Raizen Biotecnologia S.A. report to view the information.
Registered Capital:
Purchase the Raizen Biotecnologia S.A. report to view the information.
Incorporation Date:
April 24, 2008
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Raizen Biotecnologia S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BRL. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
55.12%
Net Profit (Loss) for the Period
-3300.87%
Total equity
-399.95%
Return on Equity (ROE)
68.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?